Home >  News >  June, 2014

FDA Says More Decisions on Morcellation Coming

The agency will hold a public meeting in July.

Published: June 12, 2014

Will morcellation devices used to laparoscopically remove uterine fibroids be recalled or banned? The FDA is convening a meeting next month to take up the topic.

The agency issued an advisory in April, discouraging their use because the devices can spread cancerous tissue in women with undetected uterine sarcomas, a condition the agency says may affect as many as 1 in every 350 women.

However, proponents of morcellation say the proportion of women with undetected sarcomas is likely closer to 1 in 1,000; that the prognosis is already bleak for those women; and that for everyone else, the alternatives are typically much more dangerous and invasive.

The FDA's Medical Devices Advisory Committee will hold a public meeting on July 10 and 11 and plans to "make recommendations regarding the appropriate use, premarket testing, labeling, and other risk mitigations" for morcellators.

One stock analyst, Greg Chodaaczek of Sterne Agee, says the meeting is likely to result in a so-called black-box warning, saying he doesn't think there's enough data to warrant a recall or ban.

Jim Burger


Also in the News...

CRNA Faces 10 Years in Prison for Allegedly Diverting Fentanyl
Legislation Would Outlaw Surgical Smoke in Calif. ORs
Jury Says ConMed Subsidiary Made False Claims in Advertising, Awards $12M in Damages
His Mastermind Ophthalmologist Father Dead, Oregon Man Sentenced in Healthcare Fraud Case
Certain Disorders May Increase Risk of Prolonged Opioid Use
Jury: Surgical Gowns Didn't Protect as Promised
U.S. Lawmakers Introduce ASC Quality and Access Act

New to Outpatient Surgery Magazine?
Sign-up to continue reading this article.
Register Now
Have an account? Please log in:
Email Address:
  Remember my login on this computer

advertiser banner

Other Articles That May Interest You

Nurses Being Turned Away at Canadian Border

Emails Show Barry Cadden Tried to Cover His Tracks After His Lab Shipped Contaminated Steroids

"No more fudging. No more BS. We must clean up all of our processes," NECC President Barry Cadden wrote in one email.

Bill Promotes Pricing Transparency and Protects Physicians From EHR Penalties

The Senate is expected to vote on the 21st Century Cures Act early next week.